Comparative time–kill study of doxycycline, tigecycline, sulbactam, and imipenem against several clones of Acinetobacter baumannii
- 31 July 2008
- journal article
- research article
- Published by Elsevier BV in Diagnostic Microbiology and Infectious Disease
- Vol. 61 (3), 309-314
- https://doi.org/10.1016/j.diagmicrobio.2008.02.014
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001–2004)Clinical Microbiology & Infection, 2006
- Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecyclineInternational Journal of Antimicrobial Agents, 2005
- Comparative in vitro bactericidal activity between cefepime and ceftazidime, alone and associated with amikacin, against carbapenem-resistant Pseudomonas aeruginosa strainsDiagnostic Microbiology and Infectious Disease, 2000
- In Vitro Activities of Nontraditional Antimicrobials against Multiresistant Acinetobacter baumannii Strains Isolated in an Intensive Care Unit OutbreakAntimicrobial Agents and Chemotherapy, 2000
- Doxycycline Is a Cost-effective Therapy for Hospitalized Patients With Community-Acquired PneumoniaArchives of Internal Medicine, 1999
- Worldwide emergence of carbapenem-resistant Acinetobacter spp.Journal of Antimicrobial Chemotherapy, 1998
- Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2The Lancet, 1998
- Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological featuresClinical Microbiology Reviews, 1996
- Imipenem kinetics in serum, lung tissue and pericardial fluid in patients undergoing thoracotomyJournal of Antimicrobial Chemotherapy, 1987
- DoxycyclineTherapeutic Drug Monitoring, 1982